Monetary Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.7M Sell
14,775
-875
-6% -$894K 3.64% 5
2026
Q1
$14.4M Sell
15,650
-305
-2% -$309K 3.44% 5
2025
Q4
$17.1M Sell
15,955
-400
-2% -$382K 3.96% 5
2025
Q3
$12.5M Buy
16,355
+75
+0.5% +$55.8K 2.87% 5
2025
Q2
$12.7M Sell
16,280
-105
-0.6% -$81.6K 3.12% 5
2025
Q1
$13.5M Sell
16,385
-85
-0.5% -$70.7K 3.66% 4
2024
Q4
$12.7M Buy
16,470
+340
+2% +$282K 3.3% 4
2024
Q3
$14.3M Sell
16,130
-175
-1% -$157K 3.67% 4
2024
Q2
$14.8M Sell
16,305
-470
-3% -$376K 3.9% 4
2024
Q1
$13.1M Sell
16,775
-290
-2% -$206K 3.64% 4
2023
Q4
$9.95M Sell
17,065
-185
-1% -$108K 3.1% 3
2023
Q3
$9.27M Sell
17,250
-100
-0.6% -$51.5K 3.09% 3
2023
Q2
$8.14M Sell
17,350
-1,170
-6% -$491K 2.49% 6
2023
Q1
$6.36M Sell
18,520
-60
-0.3% -$20.2K 1.87% 9
2022
Q4
$6.8M Sell
18,580
-855
-4% -$303K 2.12% 7
2022
Q3
$6.28M Sell
19,435
-1,765
-8% -$559K 2.07% 8
2022
Q2
$6.87M Sell
21,200
-225
-1% -$67.5K 2.15% 8
2022
Q1
$6.13M Sell
21,425
-120
-0.6% -$30.9K 1.63% 9
2021
Q4
$5.95M Buy
21,545
+1,835
+9% +$465K 1.47% 11
2021
Q3
$4.55M Buy
19,710
+450
+2% +$111K 1.25% 18
2021
Q2
$4.42M Sell
19,260
-425
-2% -$85.4K 1.33% 15
2021
Q1
$3.68M Buy
19,685
+500
+3% +$97.8K 1.16% 17
2020
Q4
$3.24M Hold
19,185
1.07% 22
2020
Q3
$2.84M Buy
19,185
+4,560
+31% +$706K 1.01% 24
2020
Q2
$2.4M Sell
14,625
-650
-4% -$99.8K 0.91% 32
2020
Q1
$2.12M Sell
15,275
-375
-2% -$51.5K 0.94% 32
2019
Q4
$2.06M Sell
15,650
-100
-0.6% -$11.6K 0.75% 40
2019
Q3
$1.76M Sell
15,750
-100
-0.6% -$11.1K 0.67% 48
2019
Q2
$1.76M Hold
15,850
0.67% 47
2019
Q1
$2.06M Sell
15,850
-450
-3% -$54.7K 0.81% 39
2018
Q4
$1.89M Sell
16,300
-550
-3% -$61.4K 0.85% 37
2018
Q3
$1.81M Sell
16,850
-100
-0.6% -$10K 0.69% 44
2018
Q2
$1.45M Hold
16,950
0.59% 45
2018
Q1
$1.31M Sell
16,950
-450
-3% -$36.2K 0.54% 51
2017
Q4
$1.47M Sell
17,400
-100
-0.6% -$8.51K 0.59% 47
2017
Q3
$1.5M Sell
17,500
-35
-0.2% -$2.87K 0.63% 47
2017
Q2
$1.44M Buy
17,535
+675
+4% +$55.1K 0.59% 55
2017
Q1
$1.42M Hold
16,860
0.62% 55
2016
Q4
$1.24M Sell
16,860
-350
-2% -$26.1K 0.57% 57
2016
Q3
$1.38M Hold
17,210
0.64% 55
2016
Q2
$1.35M Buy
17,210
+250
+1% +$18.8K 0.63% 58
2016
Q1
$1.22M Sell
16,960
-375
-2% -$28.4K 0.59% 61
2015
Q4
$1.46M Buy
17,335
+750
+5% +$62.2K 0.7% 47
2015
Q3
$1.39M Sell
16,585
-500
-3% -$42.2K 0.69% 49
2015
Q2
$1.43M Sell
17,085
-200
-1% -$15.2K 0.64% 50
2015
Q1
$1.26M Sell
17,285
-700
-4% -$49.8K 0.55% 56
2014
Q4
$1.24M Hold
17,985
0.55% 62
2014
Q3
$1.17M Buy
17,985
+100
+0.6% +$6.33K 0.54% 58
2014
Q2
$1.11M Buy
17,885
+4,160
+30% +$248K 0.52% 63
2014
Q1
$808K Sell
13,725
-500
-4% -$27.9K 0.38% 79
2013
Q4
$725K Sell
14,225
-30,000
-68% -$1.5M 0.34% 83
2013
Q3
$2.23M Buy
44,225
+29,675
+204% +$1.55M 1.17% 29
2013
Q2
$714K Buy
+14,550
New +$792K 0.39% 82

Other funds holding LLY

Monetary Management Group's LLY Position: Q2 2026 in Review

Monetary Management Group reduced its Eli Lilly (LLY) stake by 5.6% in Q2 2026, selling an estimated $894K and leaving 14,775 shares worth $17.7M. The position accounts for 3.64% of the portfolio, ranked #5.

Monetary Management Group first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Monetary Management Group held 14,775 shares of Eli Lilly worth $17.7M as of Q2 2026.
  • Monetary Management Group sold 875 Eli Lilly shares in Q2 2026, an estimated $894K.
  • Eli Lilly made up 3.64% of Monetary Management Group's portfolio in Q2 2026, its #5 holding.
  • Monetary Management Group first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Monetary Management Group's 13F filing for Q2 2026, filed 12 Aug 2026.